Highly active antiretroviral therapy adherence: The patient's point of view

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue SUPPL. 3, 2002, Pages

  Guarinieri, Mauro ^a  

^a EUROPEAN AIDS TREATMENT GROUP   (Belgium)

Author keywords

Activism; Adherence; Patient involvement

Indexed keywords

ANTIRETROVIRUS AGENT;

ABNORMAL BODY BUILD; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; GASTROINTESTINAL DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIVER DISEASE; LYMPHOCYTE COUNT; METABOLIC DISORDER; NEUROLOGIC DISEASE; PANCREAS DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SURVIVAL RATE; VIRUS INHIBITION; VIRUS LOAD;

EID: 0037114809     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200212153-00017     Document Type: Conference Paper

References (10)

1. Anderson TD, Sadoff JW. Home health, long-term care, and other compliance activities. Healthc Financ Manage 1999;53:48-51.
2. Richter A, Simpson KN, Manskopf JA. Impact of drug noncompliance and the frequency of viral load testing on outcomes. costs and patterns of therapy [abstract #42173]. Presented at the 12th World AIDS Conference, Geneva, June 1998.
3. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immune deficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-9.
4. Marinker M. From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. Royal Pharmaceutical Society, 1997.
5. Weiss LJ, French PT, Waters MD, et al. Adherence support: The importance of linkages to clinical care [abstract MoPeB3284]. Presented at the XIV International AIDS Conference, Barcelona. 2002.
6. Hofmann A, Vanderpuye K, Williams H. et al. Participatory theatre as a novel approach for addressing barriers to antiretroviral adherence in Harlem, NY [abstract MoPeF3963]. Presented at the XIV International AIDS Conference. Barcelona, 2002.
7. Starace F, Abrescia N, Angarano G, et al. Adherence as a gender issue: Psychosocial factors influencing antiretroviral adherence in HIV-seropositive women [abstract WePeB5854]. Presented at the XIV International AIDS Conference. Barcelona, 2002.
8. Carrieri P, Chesney MA, Spire B, et al. Failure to maintain adherence to HAART in a cohort of French HIV-infected injecting drug users [abstract ThPpB2138]. Presented at the XIV International AIDS Conference, Barcelona. 2002.
9. Lakonphon S, Ounjit N, Ponnet M. Helping children feel better about themselves enhances adherence to antiretroviral therapy [abstract TuPeG5673]. Presented at the XIV International AIDS Conference, Barcelona, 2002.
10. Catz SL, Sosman JM, Scheuerell KA, Crumble D. Antiretroviral adherence barriers in a correctional setting [abstract MoPeB3259]. Presented at the XIV International AIDS Conference. Barcelona. 2002.